Daniel J. Becker's Net Worth

-$11.7 Thousand

Estimate Recalculated Nov 11, 2024 01:52PM EST

Who is Daniel J. Becker

Daniel J. Becker does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Day One Biopharmaceuticals, Inc., Pandion Therapeutics Holdco LLC, Principia Biopharma Inc., and ACELYRIN, Inc..

SEC CIK

Daniel J. Becker's CIK is 0001752139

Past Insider Trading and Trends

2023 was Daniel J. Becker's most active year for acquiring shares with 4 total transactions. Daniel J. Becker's most active month to acquire stocks was the month of May. 2020 was Daniel J. Becker's most active year for disposing of shares, totalling 3 transactions. Daniel J. Becker's most active month to dispose stocks was the month of August. 2021 saw Daniel J. Becker paying a total of $80,000.00 for 68,000 shares, this is the most they've acquired in one year. In 2021 Daniel J. Becker cashed out on 14,997 shares for a total of $60,000.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Day One Biopharmaceuticals, Inc.

Investor
Updated Jun 26, 2023
Form 4
37.50K
Jun 26, 2023
37.50K
Grant
Jun 22
Form 4
28.70K
Jun 23, 2022
28.70K
Grant
Jun 21
Form 4
68.00K
$16.00
$80.00K
Jun 01, 2021
68.00K
Purchase
May 26 - Jun 01
Form 3
May 26, 2021
Showing 4 results

Pandion Therapeutics Holdco LLC

Investor
Updated Apr 01, 2021
Form 4
-100.00%
-2.84M
$60.00
-$169.73M
Apr 01, 2021
Disposition
Apr 01
Form 4
7.52%
197.72K
$15.12
$2.99M
Nov 23, 2020
2.83M
Purchase
Nov 19
Form 4
1.13%
29.39K
$15.29
$449.40K
Nov 19, 2020
2.63M
Purchase
Nov 17 - Nov 18
Form 4
-72.69%
-6.96M
$18.00
$18.00K
Jul 21, 2020
2.62M
Buy-Options
Jul 17 - Jul 21
Form 3
Jul 16, 2020
Showing 5 results

Principia Biopharma Inc.

Investor
Updated Sep 28, 2020
Form 4
-100.00%
-708.55K
$100.00
-$66.76M
Sep 28, 2020
Disposition
Sep 28
Form 4
10.24K
Jun 08, 2020
10.24K
Grant
Jun 04
Form 4
8.98%
55.00K
$29.94
$1.65M
Nov 22, 2019
667.60K
Purchase
Nov 20
Form 4
14.50%
77.60K
$33.48
$2.60M
Oct 30, 2019
612.60K
Purchase
Oct 28 - Oct 29
Form 4
535.00K
$28.00
$14.98M
Oct 22, 2019
535.00K
Purchase
Oct 18
Form 4
10.24K
Jun 11, 2019
10.24K
Grant
Jun 11
Form 4
20.48K
Jan 10, 2019
20.48K
Grant
Sep 13
Form 4
11.46%
270.00K
$17.00
Sep 20, 2018
2.65M
Purchase
Sep 18
Form 3
Sep 13, 2018
Showing 9 results

ACELYRIN, Inc.

Investor
Updated Jul 19, 2024
Form 4
-0.03%
-1.00
$6.86
-$6.86
Jul 19, 2024
3.00K
Sale
Jul 17
Form 4
92.16K
Jun 11, 2024
92.16K
Grant
Jun 07
Form 4
12.91%
3.00K
$18.00
$54.00K
May 11, 2023
26.24K
Purchase
May 09
Form 4
23.24K
May 04, 2023
23.24K
Grant
May 04
Form 3
May 04, 2023
Showing 5 results